Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

SELL
$9.27 - $11.41 $4,922 - $6,058
-531 Reduced 55.31%
429 $4,000
Q3 2024

Oct 04, 2024

SELL
$8.32 - $10.7 $8 - $10
-1 Reduced 0.1%
960 $10,000
Q2 2024

Jul 29, 2024

BUY
$8.01 - $8.64 $7,697 - $8,303
961 New
961 $7,000
Q2 2023

Aug 07, 2023

SELL
$8.04 - $9.0 $57,863 - $64,773
-7,197 Reduced 56.72%
5,491 $46,000
Q1 2023

Apr 25, 2023

SELL
$7.57 - $8.37 $10,620 - $11,743
-1,403 Reduced 9.96%
12,688 $103,000
Q4 2022

Jan 19, 2023

BUY
$5.96 - $8.06 $83,982 - $113,573
14,091 New
14,091 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Ridgewood Investments LLC Portfolio

Follow Ridgewood Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.